Viropro Inc.
VPRO
Rank in Stocks
#34338
Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract... Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract research and manufacturing organization (CRMO), primarily engaged in the development and production of biotherapeutic proteins aimed at treating diverse medical conditions. The company additionally facilitates the industrial-scale manufacturing of biogeneric therapeutic proteins through the licensing of its proprietary technologies, targeting illnesses like cancer, diabetes, hepatitis, and multiple sclerosis. Viropro manufactures a range of biologics drugs, including biosimilars, for use across all phases of clinical development, from pre-clinical studies through Phase I, II, and III trials. Its offerings to clients include the provision of mammalian cell proteins, such as monoclonal antibodies, recombinant proteins, and other cell-derived compounds. Notably, the firm owns three proprietary clones: two intended for insulin-related therapies and one for cancer treatment. Viropro delivers extensive contractual research and manufacturing solutions to biotech and biopharmaceutical enterprises, performing tasks such as cloning, sequencing, purification, development, validation, and production of biopharmaceutical components and finished products. The company maintains operational presences in Canada, the United Kingdom, and Malaysia, and has established a partnership with Oncobiologics, Inc. for the creation and commercialization of monoclonal antibody products. Viropro Inc. is headquartered in San Jose, California.
Share Price
$0.00002
Last synced: 2026-11-06
Market Cap
$25.40K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Viropro Inc. (VPRO)
Category
Healthcare
Operating Margin for Viropro Inc. (VPRO)
Operating Margin as of November 2026 TTM: -174.49%
According to Viropro Inc.'s latest financial reports, its current operating margin (TTM) is -174.49%. At the end of 2010 the company had an operating margin of -174.49%.
Operating Margin history for Viropro Inc. from 2003 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -174.49% | 0.00% |
| 2010 | -174.49% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | -100.00% |
| 2007 | -672.64% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.22% |
US
|
|
| -149.01% | -99.15% |
US
|
|
| 25.57% | -100.15% |
AU
|
|
| 31.23% | -100.18% |
BE
|
|
| 29.35% | -100.17% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Viropro Inc.'s operating margin
What is Viropro Inc.'s operating margin?
Viropro Inc.'s operating margin is -174.49%, as of Nov 2026.
What was Viropro Inc.'s operating margin in 2010?
In 2010, Viropro Inc.'s operating margin was -174.49%, compared with 0.00% in 2009.
How has Viropro Inc.'s operating margin changed since 2005?
From 2005 to 2010, Viropro Inc.'s operating margin was highest in 2009 (0.00%) and lowest in 2007 (-672.64%).
How does Viropro Inc.'s operating margin compare with similar companies?
Viropro Inc.'s operating margin (-174.49%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.